Virtual Clinical Trials Market 2027 By Type (Interventional Trials, Observational Trials, Expanded Access Trials. On the basis of implications, the market is categorized as Cardiovascular Disease, Onc

Virtual Clinical Trials Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Interventional Trials, Observational Trials, Expanded Access Trials. On the basis of implications, the market is categorized as Cardiovascular Disease, Oncology, and Geography

Report Code: TIPRE00015768 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Covid
MARKET INTRODUCTION

Virtual Clinical Trials, also known as remote or decentralised trials, are a relatively recent and still underutilised way of performing clinical testing that takes full advantage of technology such as apps, electronic surveillance systems and online social interaction networks.

MARKET DYNAMICS

There has recently been an increase in the number and complexity of clinical trials, which play a significant role in the R&D of new medications and other products. Clinical experiments have now been more expensive projects, leading to the total expense of producing a medication. Big pharmaceutical companies, as well as small biotechnological companies, are therefore searching for new ways to boost research performance and cut trial costs.

MARKET SCOPE

The "Virtual Clinical Trials Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Virtual Clinical Trials Market with detailed market segmentation by type and implications. The Virtual Clinical Trials Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Virtual Clinical Trials Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Virtual Clinical Trials Market is segmented on the basis of type and implications. Based on type, the market is segmented as Interventional Trials, Observational Trials, Expanded Access Trials. On the basis of implications, the market is categorized as Cardiovascular Disease, Oncology.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Virtual Clinical Trials Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Virtual Clinical Trials Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Virtual Clinical Trials Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Virtual Clinical Trials market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Virtual Clinical Trials Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Virtual Clinical Trials Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Virtual Clinical Trials Market in the global market. Below mentioned is the list of few companies engaged in the Virtual Clinical Trials Market.

The report also includes the profiles of key players in Virtual Clinical Trials Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   IQVIA
  •   PAREXEL International Corporation
  •   Wuxi AppTec Inc
  •   PRA Health Sciences
  •   Pharmaceutical Product Development, LLC
  •   Charles River Laboratory
  •   ICON Plc
  •   SGS SA
  •   Chiltern International Ltd
  •   Eli Lilly and Company

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Virtual Clinical Trials Market - By Type
1.3.2 Virtual Clinical Trials Market - By Implication
1.3.3 Virtual Clinical Trials Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VIRTUAL CLINICAL TRIALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VIRTUAL CLINICAL TRIALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VIRTUAL CLINICAL TRIALS MARKET - GLOBAL MARKET ANALYSIS
6.1. VIRTUAL CLINICAL TRIALS - GLOBAL MARKET OVERVIEW
6.2. VIRTUAL CLINICAL TRIALS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VIRTUAL CLINICAL TRIALS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INTERVENTIONAL TRIALS
7.3.1. Overview
7.3.2. Interventional Trials Market Forecast and Analysis
7.4. OBSERVATIONAL TRIALS
7.4.1. Overview
7.4.2. Observational Trials Market Forecast and Analysis
7.5. EXPANDED ACCESS TRIALS
7.5.1. Overview
7.5.2. Expanded Access Trials Market Forecast and Analysis
8. VIRTUAL CLINICAL TRIALS MARKET - REVENUE AND FORECASTS TO 2027 - IMPLICATION
8.1. OVERVIEW
8.2. IMPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASE
8.3.1. Overview
8.3.2. Cardiovascular Disease Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
9. VIRTUAL CLINICAL TRIALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Virtual Clinical Trials Market Overview
9.1.2 North America Virtual Clinical Trials Market Forecasts and Analysis
9.1.3 North America Virtual Clinical Trials Market Forecasts and Analysis - By Type
9.1.4 North America Virtual Clinical Trials Market Forecasts and Analysis - By Implication
9.1.5 North America Virtual Clinical Trials Market Forecasts and Analysis - By Countries
9.1.5.1 United States Virtual Clinical Trials Market
9.1.5.1.1 United States Virtual Clinical Trials Market by Type
9.1.5.1.2 United States Virtual Clinical Trials Market by Implication
9.1.5.2 Canada Virtual Clinical Trials Market
9.1.5.2.1 Canada Virtual Clinical Trials Market by Type
9.1.5.2.2 Canada Virtual Clinical Trials Market by Implication
9.1.5.3 Mexico Virtual Clinical Trials Market
9.1.5.3.1 Mexico Virtual Clinical Trials Market by Type
9.1.5.3.2 Mexico Virtual Clinical Trials Market by Implication
9.2. EUROPE
9.2.1 Europe Virtual Clinical Trials Market Overview
9.2.2 Europe Virtual Clinical Trials Market Forecasts and Analysis
9.2.3 Europe Virtual Clinical Trials Market Forecasts and Analysis - By Type
9.2.4 Europe Virtual Clinical Trials Market Forecasts and Analysis - By Implication
9.2.5 Europe Virtual Clinical Trials Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Virtual Clinical Trials Market
9.2.5.1.1 Germany Virtual Clinical Trials Market by Type
9.2.5.1.2 Germany Virtual Clinical Trials Market by Implication
9.2.5.2 France Virtual Clinical Trials Market
9.2.5.2.1 France Virtual Clinical Trials Market by Type
9.2.5.2.2 France Virtual Clinical Trials Market by Implication
9.2.5.3 Italy Virtual Clinical Trials Market
9.2.5.3.1 Italy Virtual Clinical Trials Market by Type
9.2.5.3.2 Italy Virtual Clinical Trials Market by Implication
9.2.5.4 Spain Virtual Clinical Trials Market
9.2.5.4.1 Spain Virtual Clinical Trials Market by Type
9.2.5.4.2 Spain Virtual Clinical Trials Market by Implication
9.2.5.5 United Kingdom Virtual Clinical Trials Market
9.2.5.5.1 United Kingdom Virtual Clinical Trials Market by Type
9.2.5.5.2 United Kingdom Virtual Clinical Trials Market by Implication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Virtual Clinical Trials Market Overview
9.3.2 Asia-Pacific Virtual Clinical Trials Market Forecasts and Analysis
9.3.3 Asia-Pacific Virtual Clinical Trials Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Virtual Clinical Trials Market Forecasts and Analysis - By Implication
9.3.5 Asia-Pacific Virtual Clinical Trials Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Virtual Clinical Trials Market
9.3.5.1.1 Australia Virtual Clinical Trials Market by Type
9.3.5.1.2 Australia Virtual Clinical Trials Market by Implication
9.3.5.2 China Virtual Clinical Trials Market
9.3.5.2.1 China Virtual Clinical Trials Market by Type
9.3.5.2.2 China Virtual Clinical Trials Market by Implication
9.3.5.3 India Virtual Clinical Trials Market
9.3.5.3.1 India Virtual Clinical Trials Market by Type
9.3.5.3.2 India Virtual Clinical Trials Market by Implication
9.3.5.4 Japan Virtual Clinical Trials Market
9.3.5.4.1 Japan Virtual Clinical Trials Market by Type
9.3.5.4.2 Japan Virtual Clinical Trials Market by Implication
9.3.5.5 South Korea Virtual Clinical Trials Market
9.3.5.5.1 South Korea Virtual Clinical Trials Market by Type
9.3.5.5.2 South Korea Virtual Clinical Trials Market by Implication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Virtual Clinical Trials Market Overview
9.4.2 Middle East and Africa Virtual Clinical Trials Market Forecasts and Analysis
9.4.3 Middle East and Africa Virtual Clinical Trials Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Virtual Clinical Trials Market Forecasts and Analysis - By Implication
9.4.5 Middle East and Africa Virtual Clinical Trials Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Virtual Clinical Trials Market
9.4.5.1.1 South Africa Virtual Clinical Trials Market by Type
9.4.5.1.2 South Africa Virtual Clinical Trials Market by Implication
9.4.5.2 Saudi Arabia Virtual Clinical Trials Market
9.4.5.2.1 Saudi Arabia Virtual Clinical Trials Market by Type
9.4.5.2.2 Saudi Arabia Virtual Clinical Trials Market by Implication
9.4.5.3 U.A.E Virtual Clinical Trials Market
9.4.5.3.1 U.A.E Virtual Clinical Trials Market by Type
9.4.5.3.2 U.A.E Virtual Clinical Trials Market by Implication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Virtual Clinical Trials Market Overview
9.5.2 South and Central America Virtual Clinical Trials Market Forecasts and Analysis
9.5.3 South and Central America Virtual Clinical Trials Market Forecasts and Analysis - By Type
9.5.4 South and Central America Virtual Clinical Trials Market Forecasts and Analysis - By Implication
9.5.5 South and Central America Virtual Clinical Trials Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Virtual Clinical Trials Market
9.5.5.1.1 Brazil Virtual Clinical Trials Market by Type
9.5.5.1.2 Brazil Virtual Clinical Trials Market by Implication
9.5.5.2 Argentina Virtual Clinical Trials Market
9.5.5.2.1 Argentina Virtual Clinical Trials Market by Type
9.5.5.2.2 Argentina Virtual Clinical Trials Market by Implication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VIRTUAL CLINICAL TRIALS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VIRTUAL CLINICAL TRIALS MARKET, KEY COMPANY PROFILES
12.1. IQVIA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PAREXEL INTERNATIONAL CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. WUXI APPTEC INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PRA HEALTH SCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CHARLES RIVER LABORATORY ICON PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SGS SA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CHILTERN INTERNATIONAL LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELI LILLY AND COMPANY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. IQVIA
2. PAREXEL International Corporation
3. Wuxi AppTec Inc
4. PRA Health Sciences
5. Pharmaceutical Product Development, LLC
6. Charles River Laboratory
7. ICON Plc
8. SGS SA
9. Chiltern International Ltd
10. Eli Lilly and Company
TIPRE00015768
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking